Y/sub 3/Al/sub 5/O/sub 12/:Yb
Magnetic and fluorescent Gd<sub>2</sub>O<sub>3</sub>:Yb<sup>3+</sup>/Ln<sup>3+</sup> nanoparticles for simultaneous upconversion luminescence/MR dual modal imaging and NIR-induced photodynamic therapy
... 2 O 3 ) UCNs with bright upconversion luminescence (UCL) and high longitudinal relaxivity (r 1 ) are used for simultaneous magnetic resonance imaging (MRI)/UCL dual-modal imaging and photodynamic therapy ...
14
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... in 5 minutes, as well as almost 100% of methicil- lin-resistant Staphylococcus aureus after 15 ...walls. 12 Thus, ozone therapy disrupts the integrity of bacterial cell ...contact. 12 Ozone has been ...
16
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... cells/mL with RPMI-1640. The adjusted cells were placed in a 96-well microtiter plate in 200 µ L aliquots and cultured in the presence of T-lymphocytes mitogen (5 µ g/mL Con- canavalin A [ConA]) (Sigma Chemical ...
6
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing potentials ranging between − 80 and − 200 ...Fe 3 ...
10
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... 8 O 6 ; Sigma-Aldrich ...(NaHCO 3 ; Sigma-Aldrich ...and 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazo- lium bromide (MTT; Sigma-Aldrich ...
12
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... China). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro- mide (MTT) and dimethyl sulfoxide were obtained from Sigma-Aldrich (St Louis, ...OH 3 HCl, and potassium oxalate (Shanghai First Reagent ...
15
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... purchased: 3-(4, 5- dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) (Ameresco, Solon, OH); Z-VAD-FMK (Beyotime Biotechnology); RPMI 1640 medium and fetal calf serum (GIBCO, USA); artesunate ...
8
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Fe 3 O 4 ...Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...Fe 3 O 4 -MNPs/DNR was ...Fe 3 O 4 -MNPs/ DNR groups were ...Fe 3 O 4 -MNPs/DNR ...
6
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... m O n -SiO 2 composite flake-like, and SiO 2 -Fe m O n core-shell IONPs on cell viability, function, and mor- phology were tested 48 h postincubation in human umbilical vein endothelial cell ...using ...
11
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... daunorubicin, 5-bromotetrandrine (5-BrTet) and daunorubicin, Fe 3 O 4 -MNP, and Fe 3 O 4 -MNP coloaded with daunorubicin and 5-bromotetrandrine (Fe 3 O 4 ...
9
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... All animals were kept in stress-free, hygienic, and animal- friendly conditions (relative humidity 60% ± 10%, room tem- perature 20 ° C ± 2 ° C, and 12-hour light/dark cycle). Food and water were available ad ...
15
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... day 3 after ...day 3, and thereafter decreased ...Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...day 3 after dosing, indicating that the liver and spleen were ...
6
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... C, 5% CO 2 ...(3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) to each well for another 4 hours of incubation, then removed the culture medium and replaced with 100 µ L DMSO (dimethyl ...
11
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Fe 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...FeCl 3 injury to the abdominal aorta and at 0 min, 10 min, 20 min, 30 min, 1 h, 2 h, and 3 h after injection of the ...
14
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... Fe 3 O 4 -MNPs can alter cytokine production patterns in peripheral blood, enzyme-linked immunosorbent assay was ...Fe 3 O 4 -MNPs altered the production of IL-2, INF- γ , and ...Fe 3 ...
7
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... All the materials used in this study were of analytical grade and required no further purification. Iron (II) chloride tetra- hydrate (FeCl 2 ⋅ 4H 2 O $ 99%) and iron (III) chloride hexahy- drate (FeCl 3 ⋅ ...
12
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Fe 3 O 4 was washed twice with distilled water, dried, and suspended using normal saline (final concentration ...for 5 minutes at 2500 rpm; the supernatant was then removed and OD values were ...
10
Synthesis, Characterization and Gas Sensing Performance of PbMnO<sub>3</sub>, PbMnO<sub>3 </sub>: SiO<sub>2</sub> and PbMnO<sub>3 </sub>: Al<sub>2</sub>O<sub>3</sub>
... In recent years, there has been interest in perovskite type of metal oxides containing manganese. These materials show interesting magnetic and electric properties, such as magneto resistivity, nanoscale charge ordering ...
10
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... MgNPs-Fe 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment with MgNPs-Fe ...
10
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... Fe 3 O 4 @SiO 2 -based drug delivery system that combines three properties: magnetic targeting, TfR targeting, and high DOX ...Fe 3 O 4 @ SiO 2 nanoparticle (DMP) was synthesized as a ...Fe ...
9